|

S-1 & Oxaliplatin Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Phase 2: 2

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1
  • Fudan University1

Indications

  • Cancer2
  • Gastric Cancer or Gastroesophageal Junction Adenocarcinoma1
  • Gastric Adenocarcinoma1

Other2 trials

A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 2
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.